A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186

David A. Macdonald, Sarit E. Assouline, Joseph Brandwein, Suzanne Kamel-Reid, Elizabeth A. Eisenhauer, Stephen Couban, Stephen Caplan, Alison Foo, Wendy Walsh, Brian Leber

Résultat de recherche: Article › examen par les pairs

40 Citations (Scopus)

Empreinte numérique

Plonger dans les sujets de recherche 'A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: Trial IND.186'. Ensemble, ils forment une empreinte numérique unique.

Medicine & Life Sciences